Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 236

1.

Low etiologic fraction for high-risk human papillomavirus in oral cavity squamous cell carcinomas.

Lingen MW, Xiao W, Schmitt A, Jiang B, Pickard R, Kreinbrink P, Perez-Ordonez B, Jordan RC, Gillison ML.

Oral Oncol. 2013 Jan;49(1):1-8. doi: 10.1016/j.oraloncology.2012.07.002. Epub 2012 Jul 28.

2.

Validation of methods for oropharyngeal cancer HPV status determination in US cooperative group trials.

Jordan RC, Lingen MW, Perez-Ordonez B, He X, Pickard R, Koluder M, Jiang B, Wakely P, Xiao W, Gillison ML.

Am J Surg Pathol. 2012 Jul;36(7):945-54. doi: 10.1097/PAS.0b013e318253a2d1.

PMID:
22743284
3.

Biomarkers of HPV in head and neck squamous cell carcinoma.

Liang C, Marsit CJ, McClean MD, Nelson HH, Christensen BC, Haddad RI, Clark JR, Wein RO, Grillone GA, Houseman EA, Halec G, Waterboer T, Pawlita M, Krane JF, Kelsey KT.

Cancer Res. 2012 Oct 1;72(19):5004-13. doi: 10.1158/0008-5472.CAN-11-3277. Epub 2012 Sep 18.

4.

Human papillomavirus infections and upper aero-digestive tract cancers: the ARCAGE study.

Anantharaman D, Gheit T, Waterboer T, Abedi-Ardekani B, Carreira C, McKay-Chopin S, Gaborieau V, Marron M, Lagiou P, Ahrens W, Holcátová I, Merletti F, Kjaerheim K, Talamini R, Simonato L, Castellsague X, Macfarlane TV, Biggs AM, Thakker N, Znaor A, Thomson P, Canova C, Conway DI, Healy CM, Tommasino M, Pawlita M, Brennan P.

J Natl Cancer Inst. 2013 Apr 17;105(8):536-45. doi: 10.1093/jnci/djt053. Epub 2013 Mar 16.

5.

Paxillin promotes tumor progression and predicts survival and relapse in oral cavity squamous cell carcinoma by microRNA-218 targeting.

Wu DW, Chuang CY, Lin WL, Sung WW, Cheng YW, Lee H.

Carcinogenesis. 2014 Aug;35(8):1823-9. doi: 10.1093/carcin/bgu102. Epub 2014 Apr 29.

PMID:
24894864
6.

p16 immunohistochemistry can be used to detect human papillomavirus in oral cavity squamous cell carcinoma.

Duncan LD, Winkler M, Carlson ER, Heidel RE, Kang E, Webb D.

J Oral Maxillofac Surg. 2013 Aug;71(8):1367-75. doi: 10.1016/j.joms.2013.02.019. Epub 2013 May 1.

PMID:
23642549
7.

Risk stratification of early stage oral tongue cancers based on HPV status and p16 immunoexpression.

Ramshankar V, Soundara VT, Shyamsundar V, Ramani P, Krishnamurthy A.

Asian Pac J Cancer Prev. 2014;15(19):8351-9.

8.

Human papillomavirus in oropharyngeal squamous cell carcinoma: assessing virus presence in normal tissue and activity in cervical metastasis.

Laborde RR, Janus JR, Olsen SM, Wang VW, Garcia JJ, Graham RP, Moore EJ, Olsen KD, Kasperbauer JL, Price DL, Berres M, Halling G, Smith DI.

Laryngoscope. 2012 Dec;122(12):2707-11. doi: 10.1002/lary.23516. Epub 2012 Sep 7.

PMID:
22961429
9.

Detection of HPV in mouth floor squamous cell carcinoma and its correlation with clinicopathologic variables, risk factors and survival.

Simonato LE, Garcia JF, Sundefeld ML, Mattar NJ, Veronese LA, Miyahara GI.

J Oral Pathol Med. 2008 Nov;37(10):593-8. doi: 10.1111/j.1600-0714.2008.00704.x.

PMID:
19012621
10.

Molecular characterization of p16-immunopositive but HPV DNA-negative oropharyngeal carcinomas.

Rietbergen MM, Snijders PJ, Beekzada D, Braakhuis BJ, Brink A, Heideman DA, Hesselink AT, Witte BI, Bloemena E, Baatenburg-De Jong RJ, Leemans CR, Brakenhoff RH.

Int J Cancer. 2014 May 15;134(10):2366-72. doi: 10.1002/ijc.28580. Epub 2013 Nov 19.

11.

Transcriptionally-active high-risk human papillomavirus is rare in oral cavity and laryngeal/hypopharyngeal squamous cell carcinomas--a tissue microarray study utilizing E6/E7 mRNA in situ hybridization.

Lewis JS Jr, Ukpo OC, Ma XJ, Flanagan JJ, Luo Y, Thorstad WL, Chernock RD.

Histopathology. 2012 May;60(6):982-91. doi: 10.1111/j.1365-2559.2011.04169.x. Epub 2012 Feb 23.

PMID:
22360821
12.

Detection of transcriptionally active high-risk HPV in patients with head and neck squamous cell carcinoma as visualized by a novel E6/E7 mRNA in situ hybridization method.

Bishop JA, Ma XJ, Wang H, Luo Y, Illei PB, Begum S, Taube JM, Koch WM, Westra WH.

Am J Surg Pathol. 2012 Dec;36(12):1874-82. doi: 10.1097/PAS.0b013e318265fb2b.

13.

Role of human papilloma virus in oral tongue squamous cell carcinoma.

Elango KJ, Suresh A, Erode EM, Subhadradevi L, Ravindran HK, Iyer SK, Iyer SK, Kuriakose MA.

Asian Pac J Cancer Prev. 2011;12(4):889-96.

14.

Biological and clinical relevance of transcriptionally active human papillomavirus (HPV) infection in oropharynx squamous cell carcinoma.

Jung AC, Briolat J, Millon R, de Reyniès A, Rickman D, Thomas E, Abecassis J, Clavel C, Wasylyk B.

Int J Cancer. 2010 Apr 15;126(8):1882-94. doi: 10.1002/ijc.24911.

15.

The prognostic role of sex, race, and human papillomavirus in oropharyngeal and nonoropharyngeal head and neck squamous cell cancer.

Fakhry C, Westra WH, Wang SJ, van Zante A, Zhang Y, Rettig E, Yin LX, Ryan WR, Ha PK, Wentz A, Koch W, Richmon JD, Eisele DW, D'Souza G.

Cancer. 2017 May 1;123(9):1566-1575. doi: 10.1002/cncr.30353. Epub 2017 Feb 27.

PMID:
28241096
16.

No evidence for active human papillomavirus (HPV) in fields surrounding HPV-positive oropharyngeal tumors.

Rietbergen MM, Braakhuis BJ, Moukhtari N, Bloemena E, Brink A, Sie D, Ylstra B, Baatenburg de Jong RJ, Snijders PJ, Brakenhoff RH, Leemans CR.

J Oral Pathol Med. 2014 Feb;43(2):137-42. doi: 10.1111/jop.12123. Epub 2013 Oct 11.

PMID:
24118314
17.

Verrucous carcinomas of the head and neck, including those with associated squamous cell carcinoma, lack transcriptionally active high-risk human papillomavirus.

Patel KR, Chernock RD, Zhang TR, Wang X, El-Mofty SK, Lewis JS Jr.

Hum Pathol. 2013 Nov;44(11):2385-92. doi: 10.1016/j.humpath.2013.07.011. Epub 2013 Sep 24.

PMID:
24071016
18.

HPV DNA, E6/E7 mRNA, and p16INK4a detection in head and neck cancers: a systematic review and meta-analysis.

Ndiaye C, Mena M, Alemany L, Arbyn M, Castellsagué X, Laporte L, Bosch FX, de Sanjosé S, Trottier H.

Lancet Oncol. 2014 Nov;15(12):1319-31. doi: 10.1016/S1470-2045(14)70471-1. Epub 2014 Oct 16. Erratum in: Lancet Oncol. 2015 Jun;16(6):e262.

PMID:
25439690
19.

Low prevalence of high risk genotypes of human papilloma virus in normal oral mucosa, oral leukoplakia and verrucous carcinoma.

Saghravanian N, Ghazvini K, Babakoohi S, Firooz A, Mohtasham N.

Acta Odontol Scand. 2011 Nov;69(6):406-9. doi: 10.3109/00016357.2011.572560. Epub 2011 Apr 5.

PMID:
21466259
20.

Evidence for a causal association between human papillomavirus and a subset of head and neck cancers.

Gillison ML, Koch WM, Capone RB, Spafford M, Westra WH, Wu L, Zahurak ML, Daniel RW, Viglione M, Symer DE, Shah KV, Sidransky D.

J Natl Cancer Inst. 2000 May 3;92(9):709-20.

PMID:
10793107

Supplemental Content

Support Center